Research Letter
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants
JAMA Internal Medicine 10.1001/jamainternmed.2025.5465October 27, 2025 at 11:00 AM EDT
This study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.